Baseline characteristics of study subjects by treatment group
| Treatment group | ||
|---|---|---|
| CGM | Control | |
| n | 67 | 62 |
| Female sex | 36 (54) | 32 (52) |
| Age (years) | 29.3 ± 16.3 | 32.0 ± 17.7 |
| ≥25 | 34 (51) | 33 (53) |
| 15–24 | 15 (22) | 18 (29) |
| 8–14 | 18 (27) | 11 (18) |
| Race: non-Hispanic white | 63 (94) | 58 (94) |
| Duration of diabetes by age-group | ||
| ≥25 years old | 25.6 ± 16.6 | 28.6 ± 12.7 |
| 15–24 years old | 8.7 ± 5.3 | 8.1 ± 4.5 |
| 8–14 years old | 4.9 ± 2.6 | 4.4 ± 3.2 |
| Insulin modality | ||
| Pump | 62 (93) | 49 (79) |
| Multiple daily injections | 5 (7) | 13 (21) |
| Total daily dose of insulin by age-group (units/kg) | ||
| ≥25 years old | 0.5 ± 0.1 | 0.5 ± 0.1 |
| 15–24 years old | 0.7 ± 0.2 | 0.8 ± 0.2 |
| 8–14 years old | 0.8 ± 0.1 | 0.8 ± 0.3 |
| A1C (%) | 6.4 ± 0.5 | 6.5 ± 0.3 |
| One or more severe hypoglycemia events* in last 6 months | 7 (10) | 7 (11) |
| Home glucose meter readings per day† | 7.3 ± 2.4 | 6.8 ± 2.4 |
| College graduate (subject or primary care giver) | 58 (87) | 55 (89) |